Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000502305 | SCV000595039 | likely benign | not specified | 2015-09-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000881606 | SCV001024793 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000881606 | SCV001906862 | benign | not provided | 2020-09-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002404310 | SCV002709119 | likely benign | Inborn genetic diseases | 2014-08-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV000881606 | SCV005206750 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000881606 | SCV001973596 | uncertain significance | not provided | no assertion criteria provided | clinical testing |